Ultragenyx Pharmaceutical (RARE) Net Margin Growth (1y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -3,082.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,120.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -653.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,849.00 |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | -2,740.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,740.00 |
| Dec 31, 2025 | -32,246.00 |
| Sep 30, 2025 | -1,709.00 |
| Jun 30, 2025 | 2,047.00 |
| Mar 31, 2025 | 4,820.00 |
| Dec 31, 2024 | 35,761.00 |
| Sep 30, 2024 | 6,711.00 |
| Jun 30, 2024 | 5,806.00 |
| Mar 31, 2024 | 633.00 |
| Dec 31, 2023 | 5,133.00 |
| Sep 30, 2023 | 10,741.00 |
| Jun 30, 2023 | 2,946.00 |
| Mar 31, 2023 | 2,739.00 |
| Dec 31, 2022 | 115.00 |
| Sep 30, 2022 | -18,082.00 |
| Jun 30, 2022 | -3,627.00 |
| Mar 31, 2022 | -5,359.00 |
| Dec 31, 2021 | -12,342.00 |
| Sep 30, 2021 | -490.00 |
| Jun 30, 2021 | -18,179.00 |
| Mar 31, 2021 | 19,084.00 |
| Dec 31, 2020 | 23,732.00 |
| Sep 30, 2020 | 35,346.00 |
| Jun 30, 2020 | 45,169.00 |
| Mar 31, 2020 | 20,463.00 |
| Dec 31, 2019 | 27,655.00 |
| Sep 30, 2019 | 30,428.00 |
| Jun 30, 2019 | 146.00 |
| Mar 31, 2019 | -81,579.00 |
| Dec 31, 2018 | 412,547.00 |
| Sep 30, 2018 | 3.93 Mn |
| Dec 31, 2017 | 142.04 Mn |
| Sep 30, 2017 | 1.85 Mn |